Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow

British Journal of Cancer

Volumn 76, Issue 9, 1997, Pages 1205-1210

  Dworkin, M J ^a   Carnochan, P ^b   Allen Mersh, T G ^a,c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Endothelin I; Laser Doppler flowmetry; Liver metastasis; Regional chemotherapy; Vasoactive manipulation

Indexed keywords

ANGIOTENSIN; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; VASOACTIVE AGENT; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HYPOTENSION; LIVER BLOOD FLOW; LIVER METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW;

EID: 0030799435     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.534     Document Type: Article

References (31)

1. Acker JC, Dewhirst MW, Honore GM, Samulski TV, Tucker JA and Oleson JR (1990) Blood perfusion measurements in human tumours: evaluation of laser Doppler methods. Int J Hyperthermia 6: 287-304
2. Ackerman NB, Jacobs R, Bloom ND and Poon TT (1988) Increased capillary flow in intrahepatic tumours due to α-adrenergic effects of catecholamines. Cancer 61: 1550-1554
3. Advanced Colorectal Cancer Metaanalysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903
4. Allen-Mersh TG (1991) Improving survival after large bowel cancer: surgeons should look for the occult (Leader). Br Med J 303: 595-596
5. Allen-Mersh TG, Earlam S, Fordy C, Abrams K and Houghton J (1994) Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255-1260
6. Almond NE and Wheatley AM (1992) Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 262: G203-G209
7. Arvidson D, Svensson H and Haglund U (1988) Laser Doppler flowmetry for estimating liver blood flow. Am J Physiol 254: G471-G476
8. Bloom ND, Kroop E and Sadjadi M (1987) Enhancement of tumor blood flow and tumouricidal effect of doxorubicin by intraportal epinepherine in experimental liver metastasis. Arch Surg 122: 1269-1272
9. Burke D, Kaur S, Carnochan P and Allen-Mersh TG (1994) Basic fibroblast growth factor increases tumour vascularity (abstract). Br J Surg 81: 1821
10. Burton MA (1987) Redistribution of blood flow in experimental hepatic tumours with noradrenaline and propanolol. Br J Cancer 56: 585-588
11. Burton MA, Gray BN, Self GW, Heggie JC and Townsend PS (1985) Manipulation of experimental rat and rabbit liver tumour blood flow with angiotensin II. Cancer Res 45: 5390-5393
12. Carter R, Cooke TG, Hemmingway D, McArdle CS and Angerson W (1992) The combination of degradable starch microspheres and angiotensin II in the manipulation of drug delivery in an animal model of colorectal metastases. Br J Cancer 65: 37-39
13. Conn HO, Ramsby GR and Storer EH (1973) Hepatic arterial escape from vasopressin induced vasoconstriction: an angiographic investigation. Am J Roent 119: 102-108
14. Currie GA and Gage JO (1973) Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeric fibrosarcoma. Br J Cancer 28: 136-146
15. Dworkin MJ and Allen-Mersh TG (1992) Regional infusion chemotherapy for colorectal liver metastases - where is it going? Cancer Treatment Rev 18: 213-224
16. Dworkin MJ, Carnochan P and Allen-Mersh TG (1995) Nitric oxide inhibition sustains vasopressin-induced vasoconstriction. Br J Cancer 71: 942-944
17. Dworkin MJ, Zweit J, Carnochan P, Dechan B and Allen-Mersh TG (1996). Effect of regional angiotensin II infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model. Eur J Cancer 9: 1580-1584
18. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele G and Frei III E (1978) A clinical-pharmacological evaluation of hepatic arterial infusions of 5-Fluoro-2-deoxyuridine and 5-Fluouracil. Cancer Res 38: 3784-3792
19. Grega G and Adamski SW (1987) Patterns of constriction produced by vasoactive agents. Fed Proc 46: 270-275
20. Hafstrom L, Nobin A, Persson B and Sundqvist K (1980) Effects of catecholamines on cardiovascular response and blood flow distribution to normal tissue and liver tumours in rats. Cancer Res 40: 481-485
21. Hemmingway DM, Cooke TG, Chang D, Grime SJ and Jenkins SA (1991) The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer 63: 495-498
22. Hemmingway DM, Angerson WJ, Anderson JH, Goldberg JA, McArdle CS and Cooke TG (1992) Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotenisn II. Br J Cancer 66: 958-960
23. Hryniuk WM, Figueredo A and Goodyear M (1987) Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin Oncol 14: (suppl.4): 3-11
24. Jain RK (1994) Barriers to drug delivery in solid tumours. Sci Am 271: 58-65
25. Kemeny N, Cohen A, Bertino JR, Sigurdson ER, Botel J and Oderman P (1990) Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer 65: 2446-2450
26. Krylova NV (1969) Characteristics of microcirculation in experimental tumours. Bibl Anat 15: 245-248
27. Mattson J, Appelgren L, Hamberger B and Peterson HI (1977) Adrenergic innervation of tumour blood vessels. Cancer Lett 347-351
28. Mattsson J and Peterson HI (1988) Influence of vasoactive drugs on tumour blood flow. Anticancer Res 1: 59-61
29. Sasaki Y, Imaoka S, Heseyawa Y, Nakano S, Ishikawa O, Ohigashi H, Taniguchi K, Koyama H, Iwanaga T and Terasawa T (1985) Changes in distribution of hepatic blood flow induced by intraarterial infusion of angiotensin II in human hepatic cancer. Cancer 55: 311-316
30. Suzuki M, Hori K, Abe I, Saito S and Sato H (1981) A new approach to cancer chemotherapy: selective enhancement of tumour blood flow with angiotensin II. J Natl Cancer Inst 67: 663-669
31. Withrington PG, de Nucci G and Vane JR (1989) Endothelin-1 causes vasoconstriction and vasodilation in the blood perfused liver of the dog. J Cardiovasc Pharmacol 13: s209-s210